New Blog — Verge Genomics

Posts in Press Release

Fierce Biotech Names Verge Genomics a 2022 “Fierce 15” Biotech Company

Fierce Biotech Names Verge Genomics a 2022 “Fierce 15” Biotech Company

Press ReleaseRob MaguireSeptember 12, 2022

Alfred W. Sandrock, Jr., M.D., Ph.D., Joins Verge Genomics’ Board of Directors

Press ReleaseRob MaguireFebruary 8, 2022

Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022

Press ReleaseRob MaguireJanuary 6, 2022

Verge Genomics Secures $98 Million in New Financing

Press ReleaseRob MaguireDecember 16, 2021

Verge Genomics Adds Independent Director Andrew Allen, M.D., Ph.D., to its Board of Directors

Press ReleaseRob MaguireSeptember 28, 2021

Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform

Press ReleaseRob MaguireJuly 8, 2021

Verge Genomics Announces the Addition of Mario Saltarelli, M.D., Ph.D., to its Scientific Advisory Board

Press ReleaseRob MaguireMay 12, 2021

Verge Genomics Announces Research Collaboration with the Sheffield Institute for Translational Neuroscience

Press ReleaseRob MaguireFebruary 2, 2021

Verge Genomics joins the Neurofilament Light Surveillance Project to Accelerate New Approaches to Diagnosing and Treating Frontotemporal Dementia

Press ReleaseRob MaguireOctober 29, 2020

Verge Genomics Announces Publication of New Approach for Uncovering Novel Drug Targets from Human Genetics

Press ReleaseRob MaguireOctober 5, 2020

Verge Genomics Announces the Addition of Rita Balice-Gordon, PhD, to its Scientific Advisory Board

Press ReleaseRob MaguireJune 24, 2020

Verge Genomics Awarded as Technology Pioneer by World Economic Forum

Press ReleaseRob MaguireJune 18, 2020

Verge Genomics to advance its inhibitors of PIKfyve for the treatment of ALS and COVID-19

Press ReleaseRob MaguireJune 11, 2020

Verge Genomics Announces the Addition of Two Renowned Neuroscience Drug Development Industry Experts to its Advisory Board

Press ReleaseRob MaguireDecember 11, 2019

Verge Genomics Appoints Jane Rhodes, Ph.D., M.B.A. as Chief Business Officer

Press ReleaseRob MaguireSeptember 11, 2019

Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discovery

Press ReleaseRob MaguireJuly 16, 2018

Verge Genomics Announces Landmark Effort to Generate Field's First Single Cell Data from Patients with Parkinson's Disease

Press ReleaseRob MaguireMay 21, 2018

Verge Genomics Announces Landmark Effort to Generate Field's First Single Cell Data from Patients with Parkinson's Disease

Press ReleaseRob MaguireMay 18, 2018

Verge Genomics joins Genomics England's Discovery Forum to transform pioneering research into frontline patient treatments

Press ReleaseRob MaguireFebruary 8, 2018

Datavant and Verge Genomics Forge Strategic Alliance to Accelerate Drug Development

Press ReleaseRob MaguireJanuary 5, 2018